Z-0128-2017 Class II Terminated

Recalled by Becton, Dickinson And Company, BD Biosciences — San Jose, CA

FDA device recall Z-0128-2017 was initiated by Becton, Dickinson And Company, BD Biosciences on Sep 21, 2016 and is designated Class II. Reason for recall: CD79b (SN8) PE is contaminated with a FITC conjugate of unknown antigenic specificity The recall status is terminated (terminated Dec 27, 2016). Affected quantity: 14 units.

Recall details

Product Type
Devices
Report Date
Oct 26, 2016
Initiation Date
Sep 21, 2016
Termination Date
Dec 27, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
14 units

Product description

CD79b PE (ASR) , Catalog number 335816 ; Hematology: The CD79b antibody recognizes an epitope on the extracellular domain of a 3640 kilodalton (kDa) type I membrane glycoprotein. Immunoglobulin (Ig) antigen receptors are composed of a non-covalently associated complex of Ig and two other proteins, Iga and Igb, which have been designated as CD79a and CD79b, respectively. antigen

Reason for recall

CD79b (SN8) PE is contaminated with a FITC conjugate of unknown antigenic specificity

Distribution pattern

Nationwide Distribution to CA, MN, OH and TX.

Code information

Lot number: 5348570; Expiration Date: 31 July 2017

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0128-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0128-2017. Report a data issue: hello@regdatalab.com.